Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-057975

VP, Clinical Trial Operations sold 36,800 shares at $11.85 ($435,995)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-07 Sale : show line 1 in the form −36,800 $11.85 $435,995 32,535 D
Open-market sales · 36,800 sh · avg $11.85 · $435,995
Loading xslF345X05/doc4.xml…